Skip to content

JALISSENSE

Active
Jules Moretuslei 175 ·2610 Antwerpen, Belgium
BE 1030.938.467
Watch Print / PDF
Turnover
EBIT margin
Net result€7k
Working capital€10k

Conclusion

the dossier summarised in one paragraph

JALISSENSE is younger than twelve months; there is no public track record yet to compute a bankruptcy probability from. The 2025 annual accounts show equity of €9k and a net result of €7k. Its solvency ranks better than 35% of 998 sector peers (fiscal year 2025). The company has been active since 2025 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 1 annual account.

Connections

1 connected company
Arega Pharma
Subsidiary · 1 location
All 1 connections

Trust signals

3 signals
Young company
Founded in 2025 — under 3 years, statistically higher risk.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.
Administratively compliant
No FOD Economie strikeouts (UBO, accounts, address, activity).

Administrative Flags

0 events
No administrative flags

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone

This company is younger than 12 months. There is no public track record yet to base a reliable estimate on — so we'd rather not show a number.

Company registry (CBE)

Crossroads Bank
Activities
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies70200Detailhandel in overige sportartikelen47639Detailhandel in auto's en lichte bestelwagens (<= 3,5 ton)47811Activiteiten van adviesbureaus op het gebied van public relations en communicatie73300Overige zakelijke dienstverlening, neg82990Overige sportactiviteiten, neg93199
Primary activity highlighted.
Names & trade names
Legal nameNL JALISSENSE
Registered office
Jules Moretuslei 175 bus 2e etage
2610 Antwerpen, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.